Price Alert

Xenetic Biosciences Inc. (XBIO)

NASDAQ: XBIO · Real-Time Price · USD

2.92

-0.00 (-0.17%)

At close: Aug 15, 2025, 2:41 PM

Xenetic Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	4.78M	5.16M	6.17M	6.84M	7.3M	7.82M	8.98M	9.78M	10.73M	11.99M	13.1M	13.85M	14.93M	16.16M	18.24M	19.7M	9.28M	10.01M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	313.92K	313.92K	1.02M	1.02M	1.02M	1.02M	704.43K	704.43K	844.43K	1.07M	1.41M	1.09M	1.09M	1.09M	704.43K	707.94K	707.94K
Receivables	n/a	n/a	n/a	n/a	716.38K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	573.85K	313.62K	n/a	188.09K	n/a	552.04K	603.83K	1.48M	1.32M	876.54K	n/a	319.1K	448.73K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	5.35M	5.48M	6.59M	7.03M	8.01M	8.38M	9.59M	11.26M	12.04M	12.87M	13.65M	14.17M	15.38M	16.89M	18.72M	20.58M	10.2M	11.04M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.96K	17.57K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	313.92K	313.92K	1.02M	1.02M	1.02M	1.02M	704.43K	704.43K	844.43K	1.07M	1.41M	1.09M	1.09M	1.09M	704.43K	715.9K	725.51K
Total Assets	5.35M	5.79M	6.9M	8.05M	9.03M	9.39M	10.61M	11.96M	12.75M	13.72M	14.72M	15.57M	16.47M	17.98M	19.82M	21.29M	10.92M	11.76M
Account Payables	346.83K	240.29K	283.62K	243.34K	283.59K	210.48K	240.83K	448.56K	221.28K	259.18K	287.36K	202.78K	472.7K	280.68K	362.47K	248.49K	305.09K	207.81K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.61K	-17.57K	-27.04K	-36.33K	-37.41K	-36.55K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	556.6K	n/a	34.2K	n/a	n/a	n/a	48.26K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	37.41K	36.55K
Total Current Liabilities	903.43K	667.93K	894.26K	1.01M	1.59M	716.49K	809.59K	1.07M	871.32K	856.37K	1.07M	1.05M	1.28M	1.06M	1.42M	1.12M	958.21K	798.19K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.96K	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	259.18K	287.36K	202.78K	472.7K	280.68K	362.47K	248.49K	7.96K	17.57K
Total Liabilities	903.43K	667.93K	894.26K	1.01M	1.59M	716.49K	809.59K	1.07M	871.32K	856.37K	1.07M	1.05M	1.28M	1.06M	1.42M	1.12M	966.17K	815.76K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.61K	17.57K	27.04K	36.33K	45.37K	54.11K
Common Stock	1.54K	1.54K	1.54K	1.54K	1.54K	1.54K	1.54K	1.54K	1.54K	15.19K	15.19K	14.34K	14.34K	13.47K	13.46K	13.41K	8.77K	8.77K
Retained Earnings	-198.79M	-198.1M	-197.19M	-196.14M	-195.7M	-194.43M	-193.23M	-192.06M	-191.01M	-189.96M	-189.1M	-187.62M	-186.81M	-184.14M	-182.55M	-180.71M	-179.35M	-178.25M
Comprehensive Income	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K	253.73K
Shareholders Equity	4.45M	5.12M	6.01M	7.04M	7.45M	8.68M	9.8M	10.89M	11.88M	12.86M	13.65M	14.52M	15.19M	16.92M	18.39M	20.16M	9.95M	10.95M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a